| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12083-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11980-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75910SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47727-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-34792-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47256-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44902 | |||
| Azide and BSA Free | NBP2-34787-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47973-0.1mg | |||
![Immunocytochemistry/Immunofluorescence: CREB [p Ser271] Antibody [NBP3-23250] - Immunocytochemical labeling of phosphorylated CREB in control and calyculin A-treated A431 cells. The cells were fixed in paraformaldehyde and permeabilized using NP-40 before labeling with rabbit polyclonal CREB (Ser-271). The antibody was detected using goat anti-rabbit DyLight(R) 594.](http://images.novusbio.com/fullsize/nbp3-23250_rabbit-creb-p-ser271-pab-1992023199286.jpg "Immunocytochemistry/Immunofluorescence: CREB [p Ser271] Antibody [NBP3-23250] - Immunocytochemical labeling of phosphorylated CREB in control and calyculin A-treated A431 cells. The cells were fixed in paraformaldehyde and permeabilized using NP-40 before labeling with rabbit polyclonal CREB (Ser-271). The antibody was detected using goat anti-rabbit DyLight(R) 594.")
![Western Blot: CREB [p Ser271] Antibody [NBP3-23250] - Western blot analysis of human A431 cells treated with calyculin A (100 nM) for 30 min. (lanes 1, 3, & 5) then blots were treated with lambda phosphatase (lanes 2, 4, & 6). The blots were probed with anti-CREB (N-terminal region) (lanes 1 & 2), anti-CREB (Ser-133) (lanes 3 & 4), and anti-CREB (Ser-271) (lanes 5 & 6).](http://images.novusbio.com/fullsize/nbp3-23250_rabbit-creb-p-ser271-pab-189202317355213.jpg)
![Immunocytochemistry/Immunofluorescence: CREB [p Ser133] Antibody (M415) [NBP3-23244] - Immunocytochemical labeling of phosphorylated CREB in calyculin A-treated A431 cells. The cells were fixed in paraformaldehyde and permeabilized using NP-40 before labeling with mouse monoclonal CREB (Ser-133). The antibody was detected using goat anti-mouse DyLight(R) 594.](http://images.novusbio.com/fullsize/nbp3-23244_mouse-creb-p-ser133-mab-m415-19920231915415.jpg "Immunocytochemistry/Immunofluorescence: CREB [p Ser133] Antibody (M415) [NBP3-23244] - Immunocytochemical labeling of phosphorylated CREB in calyculin A-treated A431 cells. The cells were fixed in paraformaldehyde and permeabilized using NP-40 before labeling with mouse monoclonal CREB (Ser-133). The antibody was detected using goat anti-mouse DyLight(R) 594.")
![Western Blot: CREB [p Ser133] Antibody (M415) [NBP3-23244] - Western blot analysis of human A431 cells treated with calyculin A (100 nM) for 30 min. (lanes 1, 3 & 5) then the blots were treated with lambda phosphatase (lanes 2, 4 & 6). The blots were probed with anti-CREB (N-terminal region) (lanes 1 & 2), anti-CREB (Ser-133) (lanes 3 & 4), and anti-CREB (Ser-271) (lanes 5 & 6).](http://images.novusbio.com/fullsize/nbp3-23244_mouse-creb-p-ser133-mab-m415-199202312523628.jpg)
![Immunocytochemistry/Immunofluorescence: Complement Component C5aR1 Antibody (S5/1) - Chimeric [NBP3-12083] - Immunofluorescence analysis of paraformaldehyde fixed U937 cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version S5/1 (NBP3-12083) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12083, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/Complement-Component-C5aR1-Antibody-S5-1-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-12083-img0001.jpg "Immunocytochemistry/Immunofluorescence: Complement Component C5aR1 Antibody (S5/1) - Chimeric [NBP3-12083] - Immunofluorescence analysis of paraformaldehyde fixed U937 cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version S5/1 (NBP3-12083) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12083, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.")
![Immunocytochemistry/Immunofluorescence: B220/CD45R Antibody (RA3-6B2) - Chimeric [NBP3-11980] - Immunofluorescence analysis of paraformaldehyde fixed mouse splenocytes immobilized on Shi-fix(TM) cover-slips and stained with the chimeric rabbit IgG version of RA3-6B2 (NBP3-11980) at 10 ug/ml followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-11980, DAPI, merged channels and an isotype control. The isotype control was stained with anti-Fluorescein antibody (NBP2-52638) followed by Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/B220-CD45R-Antibody-RA3-6B2-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-11980-img0001.jpg "Immunocytochemistry/Immunofluorescence: B220/CD45R Antibody (RA3-6B2) - Chimeric [NBP3-11980] - Immunofluorescence analysis of paraformaldehyde fixed mouse splenocytes immobilized on Shi-fix(TM) cover-slips and stained with the chimeric rabbit IgG version of RA3-6B2 (NBP3-11980) at 10 ug/ml followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-11980, DAPI, merged channels and an isotype control. The isotype control was stained with anti-Fluorescein antibody (NBP2-52638) followed by Alexa Fluor(R) 488 secondary antibody.")
![Flow Cytometry: B220/CD45R Antibody (RA3-6B2) - Chimeric [NBP3-11980] - Mouse splenocytes were stained with anti-Fluorescein IgG antibody (4-4-20; isotype control, black line) or the rabbit IgG1 version of RA3-6B2 (NBP3-11980, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-rabbit IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/B220-CD45R-Antibody-RA3-6B2-Chimeric-Flow-Cytometry-NBP3-11980-img0002.jpg)
![Immunohistochemistry: CD4 Antibody (CE9.1 (Clenoliximab)) [NBP2-75910] - Anti-CD4 staining of formaldehyde fixed paraffin embedded guinea pig skin tissue, at 40x magnification. The human IgG4-chimeric version of CE9.1 (Clenoliximab) (NBP2-75910) was used to stain samples at a concentration of 3 ug/ml.](http://images.novusbio.com/fullsize/CD4-Antibody-CE9-1-Clenoliximab-Immunohistochemistry-NBP2-75910-img0002.jpg "Immunohistochemistry: CD4 Antibody (CE9.1 (Clenoliximab)) [NBP2-75910] - Anti-CD4 staining of formaldehyde fixed paraffin embedded guinea pig skin tissue, at 40x magnification. The human IgG4-chimeric version of CE9.1 (Clenoliximab) (NBP2-75910) was used to stain samples at a concentration of 3 ug/ml.")
![Western Blot: CD4 Antibody (CE9.1 (Clenoliximab)) [NBP2-75910] - Human thyroid tumour samples were resolved on a 15% SDS PAGE gel and blots probed with the human IgG4-chimeric version of CE9.1 (NBP2-75910) at 1.5 ug/ml before detection using an anti-human IgG4 secondary antibody. Protein was detected by chemiluminescence. The expected unmodified running size for CD4 is 51kDa (arrowhead). Here some non-specific bands can also be seen. NBP2-75910 successfully detected CD4 in human thyroid tissue samples.](http://images.novusbio.com/fullsize/CD4-Antibody-CE9-1-Clenoliximab-Western-Blot-NBP2-75910-img0003.jpg)
![Immunohistochemistry-Paraffin: Insulin Antibody (IRDN/805) - IHC-Prediluted [NBP2-48273] - Human pancreas stained with Insulin Monoclonal Antibody (IRDN/805).](http://images.novusbio.com/fullsize/Insulin-Antibody-IRDN-805-IHC-Prediluted-Immunohistochemistry-Paraffin-NBP2-48273-img0001.jpg "Immunohistochemistry-Paraffin: Insulin Antibody (IRDN/805) - IHC-Prediluted [NBP2-48273] - Human pancreas stained with Insulin Monoclonal Antibody (IRDN/805).")
![Immunohistochemistry-Paraffin: CD79A Antibody (SPM550) - IHC-Prediluted [NBP2-44739] - Formalin-fixed, paraffin-embedded human Tonsil stained with CD79A Antibody (SPM550)](http://images.novusbio.com/fullsize/CD79A-Antibody-SPM550-IHC-Prediluted-Immunohistochemistry-Paraffin-NBP2-44739-img0001.jpg "Immunohistochemistry-Paraffin: CD79A Antibody (SPM550) - IHC-Prediluted [NBP2-44739] - Formalin-fixed, paraffin-embedded human Tonsil stained with CD79A Antibody (SPM550)")
![Immunohistochemistry-Paraffin: Orosomucoid 2 Antibody (D7) [NBP3-41442] - DAB staining on IHC-P; Sample: Human Liver Tissue; Primary Ab: 30ug/ml NBP3-41442; Second Ab: 2ug/mLÂ HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41442_mouse-orosomucoid-2-mab-d7-61220242151820.jpg "Immunohistochemistry-Paraffin: Orosomucoid 2 Antibody (D7) [NBP3-41442] - DAB staining on IHC-P; Sample: Human Liver Tissue; Primary Ab: 30ug/ml NBP3-41442; Second Ab: 2ug/mLÂ HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody")
![Immunohistochemistry-Paraffin: Orosomucoid 2 Antibody (D7) [NBP3-41442] - DAB staining on IHC-P; Sample: Human Prostate cancer Tissue; Primary Ab: 30ug/ml NBP3-41442; Second Ab: 2ug/mLÂ HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41442_mouse-orosomucoid-2-mab-d7-612202421351278.jpg)
![Western Blot: Orosomucoid 2 Antibody (D7) [NBP3-41442] - Sample: Lane1: Human Serum; Lane2: Rat Liver lysate; Lane3: Rat Pancreas lysate; Lane4: Rat Bladder lysate Primary Ab: 3ug/ml NBP3-41442; Second Ab: 0.2ug/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41442_mouse-orosomucoid-2-mab-d7-612202420484723.jpg)
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (SPM541) [NBP2-33013] - Formalin-paraffin colon stained with CEA MAb (SPM541)](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-SPM541-Immunohistochemistry-Paraffin-NBP2-33013-img0001.jpg "Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (SPM541) [NBP2-33013] - Formalin-paraffin colon stained with CEA MAb (SPM541)")
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (C66/195) [NBP2-44897] - Human Colon Carcinoma stained with CEA Monoclonal Antibody (C66/195).](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-C66-195-Immunohistochemistry-Paraffin-NBP2-44897-img0001.jpg "Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (C66/195) [NBP2-44897] - Human Colon Carcinoma stained with CEA Monoclonal Antibody (C66/195).")